Assessment of Clinical Presentation, Performance of Diagnostic Methods and Antibiotic Susceptibility Testing for Salmonella among Patients Attending Kangema Sub-County Hospital, Kenya
Background: Typhoid disease remains a major public health problem globally, especially in developing countries in sub-Saharan Africa. Symptoms associated with typhoid disease mimic those of other febrile illnesses and are thus difficult to make an accurate diagnosis. A confirmed diagnosis requires the determination or isolation of the bacteria in well-equipped laboratories. Developing countries are faced with a huge limitation of the laboratory infrastructure to diagnose typhoid disease, which would otherwise guide in treating, managing, controlling, and halting the spread of drug resistant mutants. Objective: This study, therefore, was aimed at determining the clinical presentation, performance of diagnostic tests and antibiotic susceptibility testing of Salmonella among adults attending Kangema Sub-County Hospital. Study Population: The study population was residents of Kangema Sub-County in Murang’a County, Kenya while the target population was adults. Methods: The study adopted a cross-sectional study design that employed a systematic random sampling procedure. The study took place between April and June 2021. The sample size was 97 respondents who all consented and were enrolled in the study. Interviewing the respondents was carried out by administering structured questionnaires to collect quantitative data. Stool samples were obtained and cultured in Cary Blair transport media and then cultured in appropriate media at the Murang’a County Referral Hospital Laboratory. A rapid Salmonella Antigen (SAT) test was also performed on all the stool samples. Data Analyses: Word Statistics and Data (STATA) v 13 was used for statistical analysis. Results: The prevalence of Typhoid Fever was at 6.2% (95% CI) which included S. Typhi (n = 1; 16.7%) and S. Paratyphi B (n = 5; 83.3%). No isolate showed resistance to Ciprofloxacin. The sensitivity of SAT is 100% and a specificity of 98.9% with a kappa statistic of almost perfect agreement (0.9641) with culture. Patients who had fever p = 0.001, abdominal distention p = 0.028, diarrhoea p = 0.038, loose or watery stool p = 0.021 and mild general condition p = 0.02 remained independently associated with Salmonella infection. Conclusion: Typhoid Fever being endemic, laboratory diagnosis was a key for confirmation after clinical diagnosis. SAT can accurately be used to detect the disease where culture is
References
[1]
World Health Organization (2018) Salmonella (Non-Typhoidal): Facts Sheet.
https://www.who.int/news-room/fact-sheets/detail/salmonella-(non-typhoidal)
[2]
Center United States Food and Drug Administration (2020) Agency of the US Department of Health and Human Services. Get the Facts about Salmonella.
https://www.fda.gov/animal-veterinary/animal-health-literacy/get-facts-about-salmonella#:~:text=Scientists%20have%20described%20more%20than%202%2C500%20Salmonella%20serotypes%2C,the%20growth%20of%20bacteria%2C%20do%20not%20kill%20Salmonella
[3]
Feasey, N.A., Dougan, G., Kingsley, R.A., Heyderman, R.S. and Gordon, M.A. (2012) Invasive Non-Typhoidal Salmonella Disease: An Emerging and Neglected Tropical Disease in Africa. The Lancet, 379, 2489-2499.
https://doi.org/10.1016/S0140-6736(11)61752-2
[4]
Crump, J.A., Sjölund-Karlsson, M., Gordon, M.A. and Parry, C.M. (2015) Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections. Clinical Microbiology Reviews, 28, 901-937. https://doi.org/10.1128/CMR.00002-15
[5]
World Health Organization (2021) Typhoid.
https://www.who.int/news-room/fact-sheets/detail/typhoid
[6]
Majowicz, S.E., Musto, J., Scallan, E., Angulo, F.J., O’Brein, S.J., Jones, T.F., Fazil, A. and Hoekstra, R.M. (2010) The Global Burden of Nontyphoidal Salmonella Gastroenteritis. Clinical Infectious Diseases, 50, 882-889.
https://doi.org/10.1086/650733
[7]
Lozano, R., Naghavi, M., Foreman, K., et al. (2012) Global and Regional Mortality from 235 Causes of Death for 20 Age Groups in 1990 and 2010: A Systematic Analysis for the Global Burden of Disease Study 2010. The Lancet, 380, 2095-2128.
https://doi.org/10.1016/S0140-6736(12)61728-0
[8]
Murray, C.J, Vos, T., Lozano, R., et al. (2012) Disability-Adjusted Life Years (DALYs) for 291 Diseases and Injuries in 21 Regions, 1990-2010: A Systematic Analysis for the Global Burden of Disease Study 2010. The Lancet, 380, 2197-2223.
https://doi.org/10.1016/S0140-6736(12)61689-4
[9]
Crump, J.A., Luby, S.P. and Mintz, E.D. (2004) The Global Burden of Typhoid Fever. Bull World Health Organ, 82, 346-353.
[10]
Stanaway, J.D., Parisi, A., Sarkar, K., et al. (2019) The Global Burden of Non-Typhoidal Salmonella Invasive Disease: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 19, 1312-1324.
https://doi.org/10.1016/S1473-3099(19)30418-9
[11]
Puyvelde, S.V., Pickard, D., Vandelannoote, K., et al. (2019) An African Salmonella Typhimurium ST313 Sublineage with Extensive Drug-Resistance and Signatures of Host Adaptation. Nature Communications, 10, Article No. 4280.
https://doi.org/10.1038/s41467-019-11844-z
[12]
Keddy, K.H., Musekiwa, A., Sooka, A., Karstaedt, A., Nana, T., Seetharam, S., Nchabaleng, M., Lekalakala, R., Angulo, F.J. and Klugman, K. (2017) Clinical and Microbiological Features of Invasive Nontyphoidal Salmonella Associated with HIV-Infected Patients, Gauteng Province, South Africa. Medicine, 96, e6448.
https://doi.org/10.1097/MD.0000000000006448
[13]
Akullian, A., Montgomery, J.M., John-Stewart, G., et al. (2018) Multi-Drug Resistant Non-Typhoidal Salmonella Associated with Invasive Disease in Western Kenya. PLOS Neglected Tropical Diseases, 12, e0006156.
https://doi.org/10.1371/journal.pntd.0006156
[14]
Kariuki, S., Mbae, C., Onsare, R., Kavai, S.M., Wairimu, C., Ngetich, R., et al. (2019) Multidrug-Resistant Nontyphoidal Salmonella Hotspots as Targets for Vaccine Use in Management of Infections in Endemic Settings. Clinical Infectious Diseases, 68, S10-S15. https://doi.org/10.1093/cid/ciy898
[15]
Lynch, M.F, Blanton, E.M, Bulens, S., Polyak, C., Vojdani, J., Stevenson, J., Medalla, F., Barzilay, E., Joyce, K., Barrett, T. and Mintz, E.D. (2009) Typhoid Fever in the United States, 1999-2006. JAMA, 302, 859-865.
https://doi.org/10.1001/jama.2009.1229
[16]
Olsen, S.J., Bleasdale, S.C., Magnano, A.R., Landrigan, C., Holland, B.H., Tauxe, R.V., Mintz, E.D. and Luby, S.P. (2003) Outbreaks of Typhoid Fever in the United States, 1960-1999. Epidemiology and Infection, 130, 13-21.
https://doi.org/10.1017/S0950268802007598
[17]
Waddington, C.S., Darton, T.C., Jones, C., Haworth, K., Peters, A., John, T. and Thompson, B.A. (2014) An Outpatient, Ambulant Design, Controlled Human Infection Model Using Escalating Doses of Salmonella Typhi Challenge Delivered in Sodium Bicarbonate Solution. Clinical Infectious Diseases, 58, 1230-1240.
https://doi.org/10.1093/cid/ciu078
[18]
Luby, S.P. (2014) Bacteria: Salmonella Typhi and Salmonella Paratyphi. Encyclopedia of Food Safety, 1, 515-522. https://doi.org/10.1016/B978-0-12-378612-8.00113-X
[19]
Jin. C., Gibani, M.M., Moore, M., Juel, H.B., Jones, E., Meiring, J., Harris, V., Gardner, J., Nebykova, A., Kerridge, S.A., et al. (2017) Efficacy and Immunogenicity of a Vi-Tetanus Toxoid Conjugate Vaccine in the Prevention of Typhoid Fever Using a Controlled Human Infection Model of Salmonella Typhi: A Randomised Controlled, Phase 2b Trial. The Lancet, 390, 2472-2480.
https://doi.org/10.1016/S0140-6736(17)32149-9
[20]
Ajibola, O., Mshelia, M.B., Gulumbe, B.H. and Eze, A.A. (2018) Typhoid Fever Diagnosis in Endemic Countries: A Clog in the Wheel of Progress? Medicina, 54, Article No. 23. https://doi.org/10.3390/medicina54020023
[21]
Parasi, A., Crump, J.A. and Glass, K. (2018) Health Outcomes from Multidrug-Resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis. Foodborne Pathogens and Disease, 15, 428-436.
https://doi.org/10.1089/fpd.2017.2403
[22]
Center for Disease Control and Prevention (2014) National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2012. Department of Health and Human Services, CDC, Atlanta.
[23]
Benacer, D., Thong, K.L., Watanabe, H. and Puthucheary, S.D. (2010) Characterization of Drug-Resistant Salmonella enterica Serotype Typhimurium by Antibiograms, Plasmids, Integrons, Resistance Genes and PFGE. Journal of Microbiology and Biotechnology, 20, 1042-1052. https://doi.org/10.4014/jmb.0910.10028
[24]
Kalonji, L.M., Post, A., Phoba, M., et al. (2015) Invasive Salmonella Infections at Multiple Surveillance Sites in the Democratic Republic of the Congo, 2011-2014. Clinical Infectious Diseases, 61, S346-S353. https://doi.org/10.1093/cid/civ713
[25]
Kariuki, S., Okoro, C., Kiiru, J., Njoroge, S., Omuse, G., Langridge, G., Kingsley, R.A., Dougan, G. and Revathi, G.S. (2015) Ceftriaxone-Resistant Salmonella enterica Serotype Typhimurium Sequence Type 313 from Kenyan Patients Is Associated with the blaCTX-M-15 Gene on a Novel IncHI2 Plasmid. Antimicrobial Agents and Chemotherapy, 59, 3133-3139. https://doi.org/10.1128/AAC.00078-15
[26]
Kenya National Bureau of Statistics (KNBS) (2019) 2019 Kenya Population and Housing Census: Volume II. Distribution of Population by Administrative Units. Nairobi.
[27]
Daniel, W.W. (1999) Biostatistics: A Foundation for Analysis in the Health Sciences. 7th Edition, John Wiley & Sons, Hoboken.
[28]
Kibiru, A.B. (2012) Risk Factors Influencing Typhoid Fever Occurrence among the Adults in Maina Slum, Nyahururu Municipality, Kenya. Kenyatta University, Nairobi.
[29]
Feng, P. (2001). Bacteriological Analytical Manual (BAM), 8th Edition, Revision A, 1998. Revised 2000-July-18, Final Revision: 2001-Jan-25.
[30]
Clinical and Laboratory Standards Institute (CLSI) (2020) M100-Performance Standards for Antimicrobial Susceptibility Testing. 30th Edition, Wayne, PA.
[31]
Aiemjoy, K., Tamrakar, D., Saha, S., Naga, S.R., Yu, A., Longley, A., Date, K., Hemlock C., Qamar, F.N., Saha, S.K., Luby, S.P., Garrett, D.O., Andrews, J.R. an d Bogoch, I.I. (2020) Diagnostic Value of Clinical Features to Distinguish Enteric Fever from Other Febrile Illnesses in Bangladesh, Nepal, and Pakistan. Clinical Infectious Diseases, 71, S257-S265. https://doi.org/10.1093/cid/ciaa1297
[32]
Kuijpers, L.M.F., Chung, P., Peeters, M., Phoba, M.F., Kham, C., Barbe, B., et al. (2018) Diagnostic Accuracy of Antigen-Based Immunochromatographic Rapid Diagnostic Tests for the Detection of Salmonella in Blood Culture Broth. PLOS ONE, 13, e0194024. https://doi.org/10.1371/journal.pone.0194024
[33]
Castonguay-Vanier, J., Davong, V., Bouthasavong, L., et al. (2013) Evaluation of a Simple Blood Culture Amplification and Antigen Detection Method for Diagnosis of Salmonella enterica Serovar Typhi Bacteremia. Journal of Clinical Microbiology, 51, 142-148. https://doi.org/10.1128/JCM.02360-12
[34]
An, B., Zhang, H., Su, X., Guo, Y., Wu, T., Ge, Y., Zhu, F. and Cui, L. (2021) Rapid and Sensitive Detection of Salmonella spp. Using CRISPR-Cas13a Combined with Recombinase Polymerase Amplification. Frontiers in Microbiology, 12, Article No. 732426. https://doi.org/10.3389/fmicb.2021.732426
[35]
Lanata, C.F., Levine, M.M., Ristori, C., Black, R.E., Jimenez, L., Salcedo, M., Garcia, J. and Sotomayor, V. (1983) Vi Serology in Detection of Chronic Salmonella typhi Carriers in an Endemic Area. The Lancet, 322, 441-443.
https://doi.org/10.1016/S0140-6736(83)90401-4
[36]
Felgner, J., Jain, A., Nakajima, R., Liang, L., Jasinskas, A., Gotuzzo, E., Vinetz, J.M., Miyajima, F., Pirmohamed, M., Hassan-Hanga, F., et al. (2017) Development of ELISAs for Diagnosis of Acute Typhoid Fever in Nigerian Children. PLOS Neglected Tropical Diseases, 11, e0005679.
https://doi.org/10.1371/journal.pntd.0005679
[37]
World Health Organization (2017) Immunization, Vaccines and Biologicals: Typhoid. http://www.who.int/immunization/diseases/typhoid/en/
[38]
Rowe, B., Ward, L.R. and Threlfall, E.J. (1997) Multidrug-Resistant Salmonella typhi: A Worldwide Epidemic. Clinical Infectious Diseases, 24, S106-S109.
https://doi.org/10.1093/clinids/24.Supplement_1.S106
[39]
Rozwandowicz, M., Brouwer, M.S.M., Fischer, J., Wagenaar, J.A., Gonzalez-Zorn, B., Guerra, B., Mevius, D.J. and Hordijk, J. (2018) Plasmids Carrying Antimicrobial Resistance Genes in Enterobacteriaceae. Journal of Antimicrobial Chemotherapy, 73, 1121-1137. https://doi.org/10.1093/jac/dkx488
[40]
Sun, F., Li, X., Wang, Y., Ge, H., Pan, Z., Xu, Y., Wang, Y., Jiao, X. and Che, X. (2021) Epidemic Patterns of Antimicrobial Resistance of Salmonella enterica Serovar Gallinarum Biovar Pullorum Isolates in China during the Past Half-Century. Poultry Science, 100, Article No. 100894. https://doi.org/10.1016/j.psj.2020.12.007
[41]
Trautmann, M., Krause, B., Birnbaum, D., Wagner, J. and Lenk, V. (1986) Serum Bactericidal Activity of Two Newer Quinolones against Salmonella typhi Compared with Standard Therapeutic Regimens. European Journal of Clinical Microbiology, 5, 297-302. https://doi.org/10.1007/BF02017785
[42]
Dan, M., Verbin, N., Gorea, A., Nagar, H. and Berger, S.A. (1987) Concentrations of Ciprofloxacin in Human Liver, Gallbladder, and Bile after Oral Administration. European Journal of Clinical Pharmacology, 32, 217-218.
https://doi.org/10.1007/BF00542200
[43]
Tamma, P.D, Cosgrove, S.E. and Maragakis, LL. (2012) Combination Therapy for Treatment of Infections with Gram-Negative Bacteria. Clinical Microbiology Reviews, 25, 450-470. https://doi.org/10.1128/CMR.05041-11
[44]
Jin, C., Gibani, M.M., Pennington, SH., Liu, X., Ardrey, A., Aljayyoussi, G., et al. (2019) Treatment Responses to Azithromycin and Ciprofloxacin in Uncomplicated Salmonella Typhi Infection: A Comparison of Clinical and Microbiological Data from a Controlled Human Infection Model. PLOS Neglected Tropical Diseases, 13, e0007955. https://doi.org/10.1371/journal.pntd.0007955
[45]
Vikrant, V., Chitnis, S., Hemvani, N. and Chitnis, D.S. (2016) Ciprofloxacin Therapy for Typhoid Fever Needs Reconsideration. Journal of Infection and Chemotherapy, 12, 402-404. https://doi.org/10.1007/s10156-006-0472-9
[46]
Qamar, F.N., Yousafzai, M.T., Dehraj, I.F., et al. (2020) Antimicrobial Resistance in Typhoidal Salmonella: Surveillance for Enteric Fever in Asia Project, 2016-2019. Clinical Infectious Diseases, 71, S276-S284. https://doi.org/10.1093/cid/ciaa1323
[47]
Aldred, K.J., Kerns, R.J. and Osheroff, N. (2014) Mechanism of Quinolone Action and Resistance. Biochemistry, 53, 1565-1574. https://doi.org/10.1021/bi5000564
[48]
Jacoby, G.A., Strahilevitz, J. and Hooper, D.C. (2014) Plasmid-Mediated Quinolone Resistance. Microbiology Spectrum, 2, 664-689.
https://doi.org/10.1128/microbiolspec.PLAS-0006-2013
